Loading…
aTyr Pharma, Inc. is projected to rise to $0.5689 by 2027, a +5% move from its current price of $0.5444. ATYR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.5125 | $0.5447 | $0.5788 | +0.05% |
| Jul 14 | $0.50 | $0.545 | $0.5939 | +0.10% |
| Jul 15 | $0.4907 | $0.5452 | $0.6058 | +0.15% |
| Jul 16 | $0.483 | $0.5455 | $0.6161 | +0.20% |
| Jul 17 | $0.4764 | $0.5458 | $0.6253 | +0.25% |
| Jul 18 | $0.4705 | $0.5461 | $0.6338 | +0.31% |
| Jul 19 | $0.4651 | $0.5463 | $0.6417 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4651 | $0.5463 | $0.6417 | +0.36% |
| Week 2 | $0.4367 | $0.5483 | $0.6884 | +0.72% |
| Week 3 | $0.4164 | $0.5502 | $0.7271 | +1.07% |
| Week 4 | $0.4003 | $0.5522 | $0.7618 | +1.44% |
| Week 5 | $0.3867 | $0.5542 | $0.7942 | +1.80% |
| Week 6 | $0.375 | $0.5562 | $0.8248 | +2.16% |
| Week 7 | $0.3646 | $0.5581 | $0.8543 | +2.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
aTyr Pharma, Inc. is a clinical stage biotechnology company that engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment of other ILDs, such as chronic hypersensitivity pneumonitis (CHP) and connective tissue disease related ILD.
The company was incorporated in 2005 and is headquartered in San Diego, California.
ATYR Pharma, Inc. trades with a current price of $0.5444 and has a market cap of $53.38M, ranking 4498. The forecasted path shows potential upside over the coming years, with long-run averages and highs expanding from 2026 through 2050.
Notable long-term milestones include 2028 avg $0.8662 with max $1.38 and 2040 avg $2.20 with max $4.84, culminating in 2050 avg $3.50 and max $8.05.
Forecasted averages rise across the horizon, for example 2026 avg $0.5444, 2027 avg $0.5689, 2028 avg $0.8662, 2029 avg $1.06, 2030 avg $0.9182, 2034 avg $1.42, 2035 avg $1.68, 2040 avg $2.20, and 2050 avg $3.50; max values reach $1.59 (2030), $2.77 (2034), $3.36 (2035), $4.84 (2040), and $8.05 (2050).
A major floor 39.0% below — a decisive break under it would weaken the trend.
The nearest floor, 19.2% below — buyers have tended to step in here.
The nearest ceiling, 20.1% above — a clean break opens room to run.
A major ceiling 91.0% above — clearing it would confirm fresh momentum.
Key ATYR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATYR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6058 | Sell | $0.5849 | Sell |
| MA 10 | $0.5903 | Sell | $0.5801 | Sell |
| MA 20 | $0.5376 | Buy | $0.5623 | Sell |
| MA 50 | $0.583 | Sell | $0.5956 | Sell |
| MA 100 | $0.7256 | Sell | $0.7305 | Sell |
| MA 200 | $0.7696 | Sell | $1.17 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.86 | Neutral |
| Stoch RSI (14) | 25.16 | Neutral |
| CCI (20) | 7.31 | Neutral |
| Williams %R (14) | -59.78 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 1.30 | Buy |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 40.22 | Neutral |
| TRIX (15) | 0.13 | Buy |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 46.90 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 0.60 | Sell |
| ADX (14) | 14.99 | Neutral |
| ATR (14) | 0.03 | Info |
Technical picture (past 30 days) shows NEUTRAL sentiment with RSI14 at 50. The SMA5o is $0.583 and the SMA200 is $0.7696 supporting a narrow trading range near the current price.
Key support sits at $0.44 and resistance at $0.654, delimiting a 30-day range from $0.3646 to $0.8129. These levels indicate limited upside momentum in the near term with a defined ceiling just above the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.396 | $0.5444 | $0.7872 | 0% | Neutral | |
| $0.4127 | $0.5689 | $0.8479 | +5% | Neutral | |
| $0.5913 | $0.8662 | $1.38 | +59% | Bullish | |
| $0.6895 | $1.06 | $1.77 | +95% | Bullish | |
| $0.5676 | $0.9182 | $1.59 | +69% | Bullish | |
| $0.621 | $1.05 | $1.89 | +93% | Bullish | |
| $0.5836 | $1.03 | $1.91 | +89% | Bullish | |
| $0.4915 | $0.9026 | $1.72 | +66% | Bullish | |
| $0.7435 | $1.42 | $2.77 | +161% | Bullish | |
| $0.8464 | $1.68 | $3.36 | +209% | Bullish | |
| $0.9921 | $2.20 | $4.84 | +305% | Bullish | |
| $1.58 | $3.50 | $8.05 | +543% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.396 | $0.5444 | $0.6934 | +0.00% |
| August 2026 | $0.4949 | $0.5997 | $0.757 | +10.16% |
| September 2026 | $0.464 | $0.5703 | $0.7349 | -4.91% |
| October 2026 | $0.4339 | $0.5398 | $0.7077 | -5.35% |
| November 2026 | $0.4532 | $0.5697 | $0.7577 | +5.54% |
| December 2026 | $0.4603 | $0.5842 | $0.7872 | +2.54% |
Click any year to see its month-by-month ATYR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ATYR is projected to trade between $0.396 and $0.7872, averaging $0.5444 — a potential gain of 0% from today's $0.5444. A consolidation phase looks the most probable path here.
aTyr Pharma, Inc.'s 2027 outlook centres on $0.5689, within a $0.4127 to $0.8479 range. That is up +5% on the projected 2026 average. That marks a +5% change versus current levels. Price action looks broadly range-bound.
By 2028, ATYR could reach as high as $1.38, with a base case around $0.8662 and support toward $0.5913 — roughly +59% from $0.5444. Buyers look set to stay in control over this stretch.
Expect ATYR to range from $0.6895 to $1.77 through 2029. The $1.06 average target implies a +95% move from current prices. That is up +23% on the projected 2028 average. Momentum favours further upside here.
The ATYR price prediction for 2030 points to an average of $0.9182 (low $0.5676, high $1.59) — a potential gain of +69% on today's $0.5444. Buyers look set to stay in control over this stretch.
In 2031, ATYR is projected to trade between $0.621 and $1.89, averaging $1.05 — a potential gain of +93% from today's $0.5444. That is up +14% on the projected 2030 average. Momentum favours further upside here.
aTyr Pharma, Inc.'s 2032 outlook centres on $1.03, within a $0.5836 to $1.91 range. That is -2% versus the projected 2031 average. That marks a +89% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ATYR could reach as high as $1.72, with a base case around $0.9026 and support toward $0.4915 — roughly +66% from $0.5444. Momentum favours further upside here.
Expect ATYR to range from $0.7435 to $2.77 through 2034. The $1.42 average target implies a +161% move from current prices. That is up +57% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ATYR price prediction for 2035 points to an average of $1.68 (low $0.8464, high $3.36) — a potential gain of +209% on today's $0.5444. Momentum favours further upside here.
In 2040, ATYR is projected to trade between $0.9921 and $4.84, averaging $2.20 — a potential gain of +305% from today's $0.5444. That is up +31% on the projected 2035 average. Buyers look set to stay in control over this stretch.
aTyr Pharma, Inc.'s 2050 outlook centres on $3.50, within a $1.58 to $8.05 range. That is up +59% on the projected 2040 average. That marks a +543% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ATYR today (≈ 1,836.884644 ATYR) could be worth
$6,431.7
+$5,431.7 (+543%) by 2050 · US Dollar
Based on the average projected ATYR price of $3.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATYRwould be worth at today's price.
$1,000 invested in ATYR on Jul 10, 2025 (≈ 187.617263 ATYR) would be worth
$102.14
-$897.86 (-89.8%) today · 0.10× · US Dollar
Based on a ATYR entry price of $5.33 vs. today's $0.5444.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.593 | $918.04 | -8.2% |
| 1 month ago | $0.468 | $1,163.25 | +16.3% |
| 3 months ago | $0.832 | $654.33 | -34.6% |
| 6 months ago | $0.683 | $797.07 | -20.3% |
| 1 year ago | $5.33 | $102.14 | -89.8% |
| All time (5.0y) ago | $4.6 | $118.35 | -88.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATYR forecast.
Our base-case forecast reaches $1.10 around 2034.
Implied market cap at $1.10: $107.86M
The multi-year forecast depicts a bullish trajectory after 2027, with years like 2028 (avg $0.8662, max $1.38, ROI 59.1) and 2029 (avg $1.06, max $1.77, ROI 95.4) showing meaningful upside and positive sentiment (BULLISH).
By 2030 the average price is forecast at $0.9182 with a max of $1.59 and ROI of 68.7, followed by continued gains through 2031-2032 (avg around $1.05-$1.03, max near $1.89-$1.91) and 2034 (avg $1.42, max $2.77, ROI 160.9). The pattern extends to 2035 (avg $1.68, max $3.36, ROI 208.7) and beyond, with 2040 (avg $2.20, max $4.84, ROI 305) and 2050 (avg $3.50, max $8.05, ROI 543.2) delivering the strongest upside.
Overall, the forecast shows a bullish sentiment across the long horizon, with substantial upside potential by 2040 and 2050, albeit these are estimates and not guarantees.
Tap a question to reveal the answer.
Avg price $0.9182; min $0.5676; max $1.59; ROI 68.7; sentiment BULLISH. These are estimates, not guarantees.
Forecasts show NEUTRAL in 2026 and 2027, then BULLISH from 2028 onward, with 2030 avg $0.9182 and 2050 max $8.05. These are projections, not guarantees, and not financial advice.
Yes, the max forecast by 2050 is $8.05, which exceeds $5. These are estimates and not guarantees.
$0.3646 to $0.8129.
Current price $0.5444; market cap $53.38M; rank 4498.
aTyr Pharma, Inc. Community Discussion
0Share your aTyr Pharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.